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Abstract 
 
Background: The hallmark of severe dengue is increased microvascular permeability however 
alterations in the microcirculation and their evolution over the course of dengue are unknown.  
Methods: We conducted a prospective observational study to evaluate the sublingual 
microcirculation using sidestream dark field imaging in patients presenting early (<72 hours fever) 
and patients hospitalized with warning signs or severe dengue in Vietnam. Clinical, microvascular 
function, global haemodynamics assessed by echocardiograms and serological markers of 
endothelial activation were performed at 4 time points. 
Results: 165 patients were enrolled. No difference was found between the microcirculatory 
parameters comparing dengue with other febrile illnesses. Proportion of perfused vessels (PPV) and 
Mean Flow Index (MFI) were lower in dengue patients with plasma leakage (PPV: 88.1% vs. 90.6%, 
P=0.010 and MFI: 2.1 vs. 2.4, P=0.007) most marked during the critical phase. PPV and MFI 
correlated with the endothelial activation markers, VCAM-1 (P<0.001 for both) and Angiopoietin-2 
(P<0.001 and P=0.001 respectively) with a negative association. 
Conclusion: Modest microcirculatory alterations occur in dengue, are associated with plasma 
leakage and correlate with molecules of endothelial activation, Angiopoietin-2 and VCAM-1.  
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Introduction 
Dengue is the most prevalent vector-borne viral illness globally, with an estimated annual incidence 
of ~96 million clinically apparent infections [1]. The majority of patients experience a self-limited 
febrile illness lasting 4-8 days. However, a small proportion develop potentially life-threatening 
complications including bleeding, organ impairment and, most importantly, plasma leakage that can 
result in hypovolaemic shock [2]. Plasma leakage manifests relatively late in the disease course with 
haemoconcentration, clinical fluid accumulation and haemodynamic compromise. However 
although the 2009 WHO classification highlights a set of warning signs intended to identify patients 
likely to progress to severe dengue, particularly shock [3], early detection of patients who develop 
significant vascular leakage remains challenging and more sensitive methods are needed [4].  
The mechanisms underlying the vascular leak syndrome remain poorly understood, but alterations 
to microvascular function through modulation of the endothelial glyocalyx layer by viral and NS1 
proteinbinding [5-7], and endothelial activation [8], have been implicated. Imbalance of vasoactive 
mediators such as TH1 cytokines, angiopoietin (Ang) 1 and 2 [9, 10], vascular endothelial growth 
factor (VEGF) and its receptors [11], and mast cell products [12], may also play a role.  A number of 
novel methods to assess microvascular function have become available in recent years, including 
sidestream dark field imaging (SDF), a technique which assesses microcirculatory flow in real-time 
using videomicroscopy [13].  SDF imaging provides semi-quantitative measurement of various 
parameters that describe vessel density, blood flow, the proportion of perfused vessels, and 
heterogeneity of flow between vessels. Recent studies using this technique in sepsis and malaria 
have demonstrated that alterations in the microcirculation are associated with organ failure and 
worse patient outcomes, and have prognostic value independent of global haemodynamics [14, 15]. 
Mechanisms that may underlie these microcirculatory alterations include reduced perfusion 
pressure, endothelial dysfunction, reduced red cell deformability, and obstruction by sequestered 
red cells in the case of severe malaria [16].  
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We hypothesized that clinical assessment of microvascular function in dengue could lead to 
identification of early markers of vascular leakage that are associated with disease progression. To 
date, visualization of the microcirculation using SDF imaging has only been described in 2 patients, 
both with dengue shock syndrome (DSS), and showed severe microcirculatory abnormalities with 
reduced flow and perfusion [17]. However neither the evolution of microcirculatory alterations over 
the disease course, nor potential associations with clinical outcomes or endothelial activation 
markers have been evaluated. 
Therefore we set out to investigate changes in the sub-lingual microcirculation in patients with 
dengue, and in a comparison group with other febrile illnesses (OFI), using SDF imaging performed at 
serial time-points throughout the disease course, aiming to explore associations with plasma leakage 
and patient outcomes. We also evaluated relationships between these microcirculatory parameters 
and global hemodynamics, as well as with serological markers of endothelial activation. 
 
Methods 
Clinical methods and patient recruitment 
We performed a STROBE [18] compliant prospective observational study at the National Hospital for 
Tropical Diseases (NHTD), Hanoi, Vietnam between June 2013 and February 2014. Ethical approvals 
were obtained from the Oxford Tropical Research Ethics Committee and the Ethics Review 
Committee at NHTD, and written informed consent was obtained from all participants or the 
parent/guardian of children. 
Adults and children above 5 years of age with a clinical diagnosis of possible dengue were eligible for 
enrolment into either of two study arms. In the outpatient arm, participants presenting within 72 
hours of fever onset could be enrolled, if no alternative cause for the fever was identified [19].  For 
the inpatient arm, any patient admitted to NHTD with suspected dengue with warning signs or 
severe dengue was eligible [3]. All patients were reviewed daily until fully recovered and afebrile, or for 
up to 6 days from enrolment. Standardized clinical information was recorded daily, including detailed 
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clinical examination and haemodynamic assessment. A full blood count was performed daily, with 
additional samples obtained for a biochemical profile and dengue diagnostics at enrolment, 
defervescence, and at a follow-up visit 10-14 days after the illness onset. Any outpatient requiring 
admission continued to be followed daily in hospital, with the indication for admission documented, and 
all management interventions recorded. Additional investigations including ultrasound examinations 
and/or chest radiology were performed if clinically indicated. 
Laboratory investigations 
Dengue diagnostics: An NS1 test (Platelia ELISA, Bio-Rad) and commercial IgM and IgG serology assays 
(Capture ELISA, Panbio, Australia) were used to confirm the diagnosis on acute and convalescent 
plasma. In addition RT-PCR was performed on enrolment samples to identify the viral serotype and 
measure plasma viremia [20]. Patients were defined as having laboratory confirmed dengue if the RT-
PCR, NS1 or IgM assays were positive at enrolment, or if there was IgM seroconversion between paired 
specimens. A diagnosis of OFI was assigned to participants with no laboratory evidence of acute or 
recent dengue – i.e. if they were negative for RT-PCR, NS1, and IgM/IgG on paired serology.  Patients 
with negative tests at enrolment, but for whom convalescent plasma was not available, were 
considered unclassifiable.  
Endothelial biomarkers: Plasma concentrations of intercellular adhesion molecule-1 (ICAM-1), 
vascular cell adhesion molecule-1 (VCAM-1), VEGF, E selectin, and Ang 1 and 2 were measured at 
four time-points; enrolment, 24 hours later, deferevescence or hospital discharge, and follow-up 10-
14 days after illness onset. These tests were performed using a magnetic bead-based assay on a 
Luminex 200 analyzer, according to the manufacturer’s specifications (R&D Systems, Abingdon, UK). 
Sublingual videomicroscopy 
SDF imaging was performed using a handheld videomicroscope with a X5 objective lens (Microvision 
Medical, Amsterdam, Netherlands) and disposable lens caps, at the same four time-points noted 
above. Image acquisition and subsequent analysis of the videos was performed using AVA 3.2 
software following consensus guidelines described previously [21]. Briefly, video clips were obtained 
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by three of the investigators (SY, LL, TTT) from 3 different sublingual sites for 60 seconds, with 
attention to minimize pressure artefacts and reduce secretions. Videos were analysed later by SY, 
VM and LL who were blind to the time-point and the disease category. The software separates 
vessels according to their size, with small vessels defined as those < 20um in diameter, and the total 
vessel density (TVD) is calculated as the number of vessels identified in the area analysed. One of the 
investigators then graded the average flow per quadrant using standardized techniques; (0=no, 
1=intermittent, 2=sluggish and 3=normal flow), allowing for calculation of the microvascular flow 
index (MFI). The flow in all vessels was then categorized as normal, intermittent, or absent, and the 
proportion of perfused vessels (PPV) was calculated. The heterogeneity of flow was determined 
using the heterogeneity index (HI), (highest minus lowest MFI/mean MFI across all the sublingual 
sites.)  Extravasated red cells (eRBC) were graded according to an internally agreed classification, as 
these have not been described using SDF imaging before; the presence of eRBC was first noted in 
each quadrant, and then scored from 0-4 with 0 indicating no eRBC seen, and 4 being eRBC noted in 
all quadrants. Intra and inter-user variability of the video analysis was checked at regular intervals, 
and was consistently <10%. 
Portable echocardiography 
Echocardiograms were performed at the bedside by one of the investigators (SY) on patients 
enrolled after September 2013, using an M-turbo Sonosite with cardiac settings. The 
echocardiograms were performed at the same time-points as SDF, and included two-dimensional, 
M-mode and Doppler studies. The following measurements were made as per standardized 
techniques: ejection fraction, stroke volume index and cardiac index (see Appendix 1).  
Clinical endpoint definitions 
The primary clinical endpoint was presence/absence of plasma leakage. A minimum dataset was 
required to fulfill this definition, encompassing all the following in addition to daily clinical 
examination;  at least 3 haematocrit recordings during the acute illness with one or more value 
obtained during the critical period (illness day 4-6); a baseline haematocrit, being the lowest value 
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(in the following order) of the follow-up sample, a sample obtained within 72 hours of fever onset, 
or, for hospitalized patients only, the discharge sample, provided no parenteral fluid therapy was 
administered within the preceding 12 hours;  a radiological assessment for vascular leakage within 
the critical period.  
Participants were classified as having no evidence of leakage if the percentage haemoconcentration 
((peak minus baseline haematocrit/baseline hematocrit) X 100) was less than 15% and there were no 
clinical or radiological signs of leakage. Conversely, if the percentage haemoconcentration was 15% 
or more, or any radiological or clinical signs of fluid accumulation were identified, the individual was 
defined as having significant vascular leakage. We also carried out a sensitivity analysis omitting the 
requirement for a radiological examination, assuming that where such a test was not deemed 
necessary by the treating clinician it would be likely to be negative.  
Other outcomes assessed included presence/absence of mucosal bleeding and overall dengue 
severity using the WHO 2009 classification; detailed information on the criteria for this is included in 
the supplementary Appendix.  
Statistical analysis 
Data are presented as frequency (percentage) for categorical variables and median (interquartile 
range) for continuous parameters. All analyses were defined a priori in a written analysis plan. First, 
comparisons of microcirculatory parameters were performed between confirmed-dengue and OFI 
patients in the outpatient arm. Among confirmed-dengue patients in both study arms, associations 
with plasma leakage and bleeding were then explored. All analyses were based on logistic regression 
models with dengue diagnosis, plasma leakage, or bleeding as the outcome of interest, and the 
microcirculatory/vascular parameters as covariates. For each covariate, an initial comparison with 
the outcome of interest used all measurements from the various time-points assessed apart from 
the follow-up values; subsequently separate analyses were performed for each disease phase: early, 
day of illness 1-3; critical, day of illness, 4-6; recovery, day of illness 7-13; and follow-up, after 14 
days or more. 
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As most patients had multiple microcirculatory measurements during the study, potentially with 
more than one measurement within each disease phase, robust sandwich standard errors based on 
working independence covariance structure were used throughout. Comparisons were adjusted for 
day of illness, age, sex, and hospitalization, as appropriate. 
Associations between microcirculation parameters, serological endothelial biomarkers and 
haemodynamics measurements in patients with dengue were assessed by partial correlations 
controlling for the following potential confounding variables: age, sex and day of illness of 
measurement. Significance of partial correlations was assessed based on their Fisher transformation 
and corresponding bootstrap standard errors. The cluster bootstrap which resamples patients rather 
than individual parameter values accounted for multiple measurements per patient. 
To informally adjust for multiplicity, a significance level of 0.01 was used for all comparisons. All 
analyses were performed with the statistical software R version 3.2.2 and the companion package 
geepack version 1.2-0. 
Results 
A total of 165 patients were enrolled, 91 in the outpatient arm and 74 in the inpatient arm (Figure 1, 
Table 1). After excluding 16 patients who withdrew or had an inconclusive diagnosis, 149 patients 
(79 and 70 in the outpatients and the inpatient arm, respectively) were included in the analysis. 
Among the outpatients, 63 participants had laboratory confirmed dengue while 16 were assigned a 
diagnosis of OFI; in the inpatient arm there were 69 confirmed dengue cases, and 1 OFI. Twenty-six 
outpatients were subsequently hospitalized (24 with confirmed-dengue and 2 OFI), but all 
participants recovered fully in the end. Considering all study participants, 50% were female and the 
median age was 26 (IQR 21-35) years. Inpatients were generally recruited slightly later in the illness 
course than outpatients, which likely explains the greater derangements observed in the laboratory 
parameters measured at enrolment.  Using the 2009 WHO classification, among the 132 confirmed 
dengue cases there were 57 (43%) with dengue, 68 (52%) dengue with warning signs and 7 (5%) 
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severe cases (Table 1). Of the 106 patients that were PCR positive, the serotypes identified were as 
follows; 21 DENV-1 (20%), 18 DENV-2 (17%), 35 DENV-3 (33%) and 32 DENV-4 (30%).  
Associations between microcirculatory parameters and dengue diagnosis 
This analysis was limited to participants enrolled in the outpatient arm of the study. No differences 
were identified between the microcirculatory variables (small vessel TVD, PPV, MFI and HI) between 
the confirmed-dengue (59 participants) and OFI (15 participants) patient groups when considered 
overall, or during any of the individual time-periods (Table 2). However, there was a trend towards 
lower MFI in the OFI compared to the dengue patients during the critical phase (P=0.045).  Time 
trends for perfusion, and mean flow are shown in Figure 2A. Considering all the time-points, a higher 
proportion (33/141, 23%) of dengue patients had eRBC seen in one or more of the video quadrants, 
but this was not significantly different to the findings in the OFI group (3/20, 15%). Collectively, 
these data indicate similar patterns of microcirculatory disturbance in the dengue and OFI patient 
groups. 
Associations between microcirculatory parameters and clinical endpoints in confirmed-dengue 
patients. 
With respect to plasma leakage, the primary analysis included all confirmed-dengue patients in both 
arms who had full clinical and radiological assessments for leakage (Table 3). There were no 
differences identified in total small vessel density (TVD) between the patients with and without 
plasma leakage at any of the time-points. However, the proportion of perfused small vessels (PPV) 
over all time-points was lower in patients with plasma leakage (median PPV: 88.1% vs. 90.6%, 
P=0.010), most markedly during the critical phase (Table 3, Figure 2B). Mean flow index (MFI) was 
also lower in the patients with plasma leakage compared to those without when considered overall 
(2.1 vs. 2.4, P=0.007). The heterogeneity index (HI) was greater for patients with plasma leakage 
compared to those without leakage (Table 3). The associations between plasma leakage and PPV, 
but not between plasma leakage and MFI or HI, were confirmed in the sensitivity analysis using the 
larger cohort classified for plasma leakage using clinical and haematocrit information only 
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(Supplementary data, Table 5). In terms of prediction, the MFI on day 3 of illness was associated with 
subsequent plasma leakage (OR = 0.39, 95% CI 0.08-0.94 per unit increase in the flow index), 
although the association did not reach significance at the predefined 1% significance level (P=0.034) 
(Supplementary data Table 6). The other microcirculatory parameters of TVD, PPV, HI and eRBC on 
days 1-3 were not predictive. 
With respect to bleeding, we found no associations between any of the microcirculatory variables 
and mucosal bleeding, except a trend for more patients with mucosal bleeding to have eRBC seen 
during the early phase (9/24, 38% vs. 8/42, 19% among patients with and without mucosal bleeding 
respectively) (Supplementary data, Table 7). Collectively, these results indicate that although 
microcirculatory indices of perfusion and flow were worse in patients with plasma leakage than in 
those without evidence of leakage, the differences observed were relatively minor. 
 
Associations between microcirculation parameters, serological endothelial biomarkers and global 
haemodynamics. 
Although plasma levels of VCAM-1 were raised, and the ratio of Ang-2/Ang-1 was increased during 
the acute dengue illness, there were no statistically significant differences between patients with 
and without plasma leakage (Figure 3). Nor were there differences between VEGF and E-selectin 
levels between patients with and without plasma leakage (data not shown). 
Amongst patients with dengue, there was a negative correlation of PPV and MFI with molecules 
associated with endothelial activation; VCAM-1 (partial correlations: -0.45, P<0.001 and -0.46 
P<0.001 respectively) and Ang-2 (partial correlations: -0.33, P<0.001 and -0.29 P=0.001). No 
associations were identified between the microcirculatory parameters assessed and the other 
endothelial biomarkers including ICAM-1, E-selectin, VEGF, and Ang-1 (Table 4). 
We found no correlations between the microcirculatory variables and global haemodynamics 
assessed contemporaneously, such as pulse, mean arterial blood pressure, stroke volume  or cardiac 
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index. Collectively, these results indicate microcirculatory parameters of flow and perfusion 
correlate negatively with endothelial activation markers, but not with global haemodynamics.  
 
Discussion 
We have shown that modest microcirculatory disturbances occur in dengue, with a reduction in 
blood flow and perfusion indices that was most marked in patients with plasma leakage during the 
critical phase of the disease. MFI and PPV were lower in patients with plasma leakage than those 
without when assessed overall during the acute illness, and the reduction in PPV was borderline 
significant during the critical phase (illness day 4-6), but not earlier in the febrile phase. These 
findings are in agreement with the only other published report assessing the microcirculation in 
dengue, which showed altered perfusion and flow during the critical phase in 2 severe dengue cases 
[17]. In addition to flow disturbances, we have shown that extravasated RBCs were visible in a 
quarter of the dengue patients assessed, a finding not previously reported in SDF studies. However, 
unlike flow disturbances the presence of eRBC was not associated with the clinical outcomes of 
interest. 
Interestingly, these microcirculatory changes do not appear to be exclusive to dengue, as similar 
disturbances were seen in the OFI group. Specific diagnoses were not established for the entire OFI 
group, but it included a mixture of other viral illnesses such as influenza, measles and acute 
hepatitis, as well as some bacterial infections including scrub typhus. Microcirculatory dysfunction 
has been demonstrated in numerous studies of severe infections including sepsis [14], and severe 
influenza [22], but this study demonstrates that some degree of microcirculatory change likely also 
occurs in less severe infections. The majority of microcirculatory studies have been performed in 
bacterial sepsis and, similar to our findings, PPV was found to be the most robust parameter 
associated with outcome [23], although higher HI indices were also associated with more severe 
disease [24].  
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Our results suggest that microcirculatory parameters assessed in the early febrile phase of dengue 
have limited prognostic potential, as the flow abnormalities generally occurred later in the disease 
course and lower MFIs on day 3 were only weakly associated with subsequently developing plasma 
leakage in the critical phase. This is also in agreement with one study performed in early sepsis, 
where microcirculatory abnormalities were not observed in the early phase of low acuity sepsis [25]. 
The mechanisms underlying the microcirculatory abnormalities observed in dengue may relate to 
increased blood viscosity, causing capillary flow to become more sluggish as plasma leakage 
progresses and haemoconcentration occurs. In addition endothelial activation may contribute to the 
flow disturbances; of the endothelial activation markers we investigated, VCAM- 1 and Ang-2 were 
negatively associated with small vessel MFI and PPV. A correlation between VCAM-1 and 
perfusion/flow parameters has previously been described in paediatric meningococcal sepsis [26]. 
The causality of the association between VCAM-1 and flow disturbances may be bidirectional,  as the 
expression of VCAM-1 is known to be up-regulated in low blood flow and sheer stress states [27], 
but also VCAM-1 mediated increases in endothelial cell-leukocyte adhesion may interfere with 
capillary flow. Ang-2 is known to be up-regulated in vessels with low flow states [28], and has been 
implicated in the haemodynamic and microvascular alterations seen in animal models of sepsis [29], 
and in pulmonary capillary leak in human sepsis [30].  
Evidence from human studies and animal models of sepsis also suggests the microcirculation 
functions independently of systemic haemodynamics, with derangements demonstrated despite 
normal mean arterial pressures (MAP) and cardiac index [31, 32]. Our data confirms this 
independence since we found no associations between the microcirculatory parameters and MAP, 
cardiac output or stroke volume. This uncoupling of micro and macro-circulations, together with the 
observation that microcirculatory  parameters correlate more closely with markers of tissue 
perfusion like lactate, has encouraged critical illness researchers to consider using the 
microcirculation as a target for goal directed therapy [33]. Fluid resuscitation has been shown to 
increase the proportion of perfused vessels and flow in early but not late septic shock, independent 
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of MAP, CI and type of fluid used [34]. Other attempts to improve the microcirculation in sepsis have 
included use of therapeutics such as activated protein C [35], and corticosteroids [36]. However 
larger randomised controlled trials are needed to link these microcirculatory improvements with 
better organ function and improved patient outcomes in severe infections.  
There were several limitations of this study. First, in the inpatient arm the patients were often 
enrolled several hours after fluid therapy had been commenced, potentially resulting in 
underestimation of the microcirculatory changes. Second, prediction modelling was limited by the 
small number of patients experiencing a severe outcome in the outpatient arm. As patients were 
generally admitted to hospital later in the disease course, early assessments (within 72 hours of 
fever onset) were rarely available for these participants, making comparisons with the outpatients 
difficult. Lastly, due to a certain level of cooperation required by patients undergoing sublingual 
videomicroscopy, we were unable to study younger children; this group are at greatest risk for 
severe plasma leakage, shock and poor outcomes [37], and may have more marked microcirculatory 
abnormalities. 
In summary, this study has identified moderate abnormalities in microcirculatory flow and perfusion 
in dengue patients, with the most severe disturbances seen in patients with plasma leakage during 
the critical phase of the disease. These disturbances were poorly specific, however, since similar 
changes occurred in patients with OFI. Perfusion indices correlated negatively with VCAM-1 and Ang 
2, suggesting endothelial activation may underlie the flow disturbances observed in dengue. 
Although microcirculatory assessment in early dengue is unlikely to be useful for risk prediction, 
future studies should be considered in established severe dengue to evaluate the utility of including 
microcirculatory perfusion outcomes alongside other haemodynamic endpoints in clinical trials 
assessing novel therapeutic strategies. 
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Figure 1. Study flow chart  
 
Figure 2A. Scatter plot showing the proportion of perfused vessels (top panel), and mean 
flow index (bottom panel), by day of illness in patients with confirmed-dengue and other 
febrile illness.  
Figure 2B. Scatter plot showing the proportion of perfused vessels (top panel) and mean 
flow index (bottom panel) by day of illness in patients with confirmed dengue with and 
without plasma leakage (primary endpoint definition) 
The short grey line represents the median value of the parameter during each illness phase. 
The numbers at the bottom of the figures represent the number of individuals that 
contributed to that group (each individual could have more than 1 measurement during the 
illness phase). Black dots represent values from patients who developed dengue shock 
syndrome. 
2A. There were no significant differences between the dengue and OFI groups for either PPV 
or MFI. 
2B. There was a significant difference between patients with and without plasma leakage 
during the acute illness (days 1-13) for both PPV (P=0.010) and MFI (P=0.007).  
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Figure 3. Scatter plot showing VCAM-1 (top panel) and angiopoietin2/1 ratio (bottom 
panel) by day of illness in patients with confirmed dengue with and without plasma 
leakage (primary endpoint definition) 
 
The short grey lines represent the median value of the parameter of interest during each 
illness phase. Black dots represent values from patients who developed dengue shock 
syndrome. The numbers at the bottom of the figures represent the numbers of individuals 
that contributed to the measurements in that illness phase. 
There were no significant differences between VCAM-1 and Ang2/1 for patients with and 
without plasma leakage. 
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Table 1. Baseline characteristics and clinical outcomes of participants 
  All patients (n=149)  Inpatient (n=70)  Outpatient (n=79) 
 n  n  n  
Baseline characteristics       
Age (years) 149 26 (21-35) 70 28.5 (21-36) 79 26 (21-33) 
Male sex 149 75 (50) 70 36 (51) 79 39 (49) 
Illness day at enrolment 149 3 (3-5) 70 5 (4-6) 79 3 (2-3) 
Confirmed-dengue 149 132 (89) 70 69 (99) 79 63 (80) 
Other febrile illness  149 17 (11) 70 1 (1) 79 16 (20) 
Platelet count (109/L) 144 121 (61-161) 67 58 (31-108) 77 151 (126-183) 
White blood cells(109/L) 144 3.9 (2.7-5.7) 67 3.4 (2.5-4.6) 77 4.5 (3.0-6.5) 
Albumin (g/L) 96 44 (40-48) 24 39 (36-45) 72 45 (42-48) 
AST (U/L) 116 34 (25 -57) 40 62 (33-117) 76 32 (23-41) 
Clinical outcomes       
Primary endpoint plasma 
leakage-yes1 
74 38 (51) 47 27 (57) 27 11 (41) 
Clinical definition plasma 
leakage-yes2  
125 30 (24) 63 21 (33) 62 9 (15) 
Mucosal bleeding 132 59 (45) 69 39 (56) 63 20 (32) 
Dengue severity3 132  69  63  
- Dengue  57 (43)  19 (28)  38 (60) 
- With warning signs  68 (52)  45 (65)  23 (37) 
- Severe  7 (5)  5 (7)  2 (3) 
Summary statistic is absolute count (%) for categorical variables and median (IQR) for continuous data, AST: 
aspartate transaminase. n refers to number of subjects with complete data for the respective characteristic 
1Plasma leakage, primary endpoint definition based on full clinical and radiological information, 2 Plasma leakage 
based on clinical and routine haematology data only. 3 Dengue severity according to the WHO 2009 classification. 
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Table 2. Small-vessel microvascular variables in study participants with confirmed-dengue versus other febrile illness, by disease phase 
   Other Febrile Illness        Dengue  OR (95% CI) p value 
 n N       n    N     
Total vessel density 
(mm/mm3) 
15 20 14.2 (12.6-15.5) 
 
59 143 14.1 (12.6-15.4) 0.92 (0.74-1.16) 0.493 
Day 1-3 9 10 14.0 (13.1-15.3)  43 58 13.4 (12.2-15.3) 0.92 (0.69-1.22) 0.554 
Day 4-6 9 10 14.3 (12.6-15.6)  48 65 14.1 (12.0-15.3) 0.96 (0.68-1.36) 0.810 
Day 7-13 0 0 -  20 20 15.3 (14.3-16.0) - - - 
Day >13 7 7 14.6 (13.0-16.4)  20 20 15.8 (14.5-17.4) 1.22 (0.70-2.12) 0.485 
Proportion of 
perfused vessels (%) 
15 20 90.3 (83.2-95.5) 
 
59 143 92.4 (87.9-95.5) 1.08 (0.99-1.17) 0.085 
Day 1-3 9 10 91.3 (85.5-94.6)  43 58 93.7 (90.2-96.1) 1.07 (0.94-1.22) 0.301 
Day 4-6 9 10 89.0 (82.0-94.2)  48 65 92.2 (88.5-95.5) 1.11 (0.98-1.27) 0.105 
Day 7-13 0 0 -  20 20 85.3 (82.5-88.9) - - - 
Day >13 7 7 98.3 (93.5, 98.7)  20 20 96.9 (96.0-97.5) 1.12 (0.74-1.70) 0.601 
Mean flow Index 15 20 2.6 (2.1, 2.7)  59 142 2.6 (2.3-2.8) 1.27 (0.98-1.64) 0.071 
Day 1-3 9 10 2.6 (2.2, 2.7)  42 57 2.6 (2.3-2.8) 1.16 (0.70-1.92) 0.574 
Day 4-6 9 10 2.4 (2.0, 2.7)  48 65 2.6 (2.4-2.8) 1.69 (1.01-2.84) 0.045 
Day 7-13 0 0 -  20 20 2.3 (2.1-2.7) - - - 
Day >13 7 7 2.7 (2.6, 2.8)  20 20 2.8 (2.8-3.0) 2.45 (0.54-11.07) 0.246 
Heterogeneity Index 14 19 0.1 (0.1, 0.2)  59 138 0.2 (0.1-0.3) 1.04 (0.80- 1.36) 0.768 
Day 1-3 8 9 0.2 (0.1, 0.3)  41 56 0.2 (0.1-0.3) 1.00 (0.68- 1.46) 0.983 
Day 4-6 9 10 0.1 (0.1, 0.2)  48 65 0.2 (0.1- 0.3) 1.01 (0.65- 1.58) 0.959 
Day 7-13 0 0 -  17 17 0.2 (0.1-0.4) - - - 
Day >13 6 6 0.1 (0.0, 0.2)  19 19 0.1 (0.0-0.1) 0.35 (0.10, 1.22) 0.099 
eRBC score >0 14 20 3 (15)  59 141 33 (23) 1.60 (0.31, 8.28) 0.576 
Day 1-3 9 10 2 (20)  42 56 13 (23) 1.24 (0.22, 7.18) 0.807 
Day 4-6 8 9 1 (11)  48 65 13 (20) 1.95 (0.24, 16.06) 0.536 
Day 7-13 1 1 0 (0)  20 20 7 (35) - - - 
Day >13 6 6 1 (17)  20 20 0 (0) - - - 
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Data are presented as absolute count (%) for categorical variables and median (IQR) for continuous data. n corresponds to number of 
participants, N corresponds to number of measurements. eRBC: extravasated red blood cells, OR: odds ratio, CI: confidence interval. 
For each variable, the highlighted rows (bolded) corresponds to the overall comparison which included all values except for values on day of 
illness > 14, and were adjusted for age, sex and day of illness. Other rows correspond to comparisons for each day of illness category, and were 
adjusted for age, sex. All comparisons were based on generalized estimating equations with independence covariance structure to take into 
account multiple measurements per patient. The OR describes the predicted change in the odds of a dengue diagnosis corresponding to an 
increase of 1mm/mm3 in TVDs, 1% in PPVs, 0.25 unit in MFIs (or increase by 1 unit in the total flow index from all 4 quadrants), 0.1 unit in HI, 
having positive eRBC score. 
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Table 3. Small-vessel microvascular variables in dengue patients with and without plasma leakage (primary endpoint definition) 
 No leakage  Plasma leakage OR (95% CI) p value 
Characteristic n N Summary statistic  n N Summary statistic    
Total vessel density 
(mm/mm3) 
33 78 14.5 (13.3-5.3) 
 
37 91 13.3 (11.8-15.0) 0.82 (0.68-0.98) 0.029 
Day 1-3 9 11 14.7 (13.3-16.2)  10 15 13.4 (11.6-14.7) 0.74 (0.51-1.07) 0.108 
Day 4-6 24 35 14.7 (13.5-15.4)  27 39 13.1 (11.6-14.9) 0.84 (0.65-1.10) 0.207 
Day 7-13 25 32 14.4 (13.4-15.2)  27 37 13.6 (12.2,-5.1) 0.85 (0.67-1.08) 0.193 
Day >13 9 9 17.2 (15.7-17.5)  13 13 14.9 (14.2-15.8) 0.46 (0.18-1.19) 0.111 
Proportion of 
perfused vessels (%) 
33 78 90.6 (85.8-94.0) 
 
37 91 88.1 (81.6-92.2) 0.94 (0.89-0.98) 0.010 
Day 1-3 9 11 94.3 (92.0-95.3)  10 15 90.9 (86.7-94.0) 0.93 (0.77-1.13) 0.489 
Day 4-6 24 35 90.8 (88.3-93.5)  27 39 87.4 (81.6-91.7) 0.89 (0.81-0.98) 0.018 
Day 7-13 25 32 88.8 (84.5-92.9)  27 37 88.1 (80.2-90.5) 0.96 (0.91-1.02) 0.162 
Day >13 9 9 97.1 (95.7-97.3)  13 13 96.0 (95.3-98.1) 1.53 (0.90-2.62) 0.119 
Mean Flow Index 33 78 2.4 (2.1-2.7)  37 90 2.1 (1.9-2.4) 0.75 (0.61-0.92) 0.007 
Day 1-3 9 11 2.8 (2.7-2.9)  9 14 2.3 (2.0-2.8) 0.24 (0.05-1.25) 0.090 
Day 4-6 24 35 2.5 (2.1-2.6)  27 39 2.0 (1.8-2.5) 0.72 (0.51-1.02) 0.063 
Day 7-13 25 32 2.2 (2.0-2.5)  27 37 2.1 (1.9-2.3) 0.81 (0.58-1.11) 0.189 
Day >13 9 9 2.9 (2.8-3.0)  13 13 2.8 (2.7-2.8) 0.12 (0.01-1.33) 0.084 
Heterogeneity Index  33 69 0.2 (0.1-0.2)  37 81 0.2 (0.1-0.3) 1.33 (1.07-1.66) 0.010 
Day 1-3 8 10 0.2 (0.1-0.2)  9 14 0.3 (0.2-0.4) 2.02 (0.95-4.31) 0.069 
Day 4-6 22 31 0.2 (0.1-0.3)  27 35 0.2 (0.1-0.3) 1.02 (0.74-1.39) 0.910 
Day 7-13 21 28 0.2 (0.1-0.2)  25 32 0.3 (0.1-0.4) 1.39 (0.97-1.99) 0.073 
Day >13 7 7 0.1 (0.0-0.1)  10 10 0.1 (0.0-0.1) 0.18 (0.0-11.65) 0.422 
Summary statistic is absolute count (%) for categorical variables and median (IQR) for continuous data. n corresponds to number of participants, 
N corresponds to number of measurements. Day: day of illness. For each variable, the highlighted rows (bolded) correspond to the overall 
comparison which included all values except for values on day of illness > 14, and was adjusted for age, sex, hospitalization and day of illness. 
Other rows correspond to comparisons for each day of illness group, which included all values obtained during that time-period. All comparisons 
were based on generalized estimating equations with independence covariance structure to take into account multiple measurements per patient. 
The OR describes the predicted change in the odds of plasma leakage corresponding to an increase of 1mm/mm3 in TVDs, 1% in PPVs, 0.25 unit 
in MFIs (or increase by 1 unit in the total flow index from all 4 quadrants), 0.1 unit in HI 
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Table 4. Partial correlation between small-vessel microcirculatory variables, endothelial biomarkers and global haemodynamics in 
patients with dengue 
  TVD   PPV   MFI 
 rho p value  rho p value  rho p value 
Serological endothelial biomarkers         
Log2 VEGF -0.254 0.061  -0.156 0.248  -0.030 0.838 
Log2 ICAM-1 -0.093 0.297  -0.136 0.178  -0.083 0.455 
Log2 VCAM-1 -0.097 0.275  -0.448 <0.001  -0.464 <0.001 
Log2 E-selectin 0.165 0.149  0.069 0.565  -0.002 0.985 
Log2 Angiopoietin 1 0.160 0.119  0.114 0.248  0.123 0.208 
Log2 Angiopoietin 2 0.042 0.611  -0.332 <0.001  -0.290 0.001 
Global haemodynamics parameters         
Pulse rate -0.019 0.797  -0.005 0.935  0.093 0.145 
Mean arterial blood pressure -0.036 0.620  0.074 0.354  -0.015 0.848 
Stroke volume index -0.161 0.163  0.096 0.443  0.122 0.444 
Cardiac Index -0.009 0.939  0.167 0.146  0.256 0.024 
 
VEGF: vascular endothelial growth factor, ICAM-1: Intercellular adhesion molecule 1, VCAM-1: Vascular cell adhesion molecule 1. Rho is the 
partial correlation coefficient between the respective two parameters of interest controlling for age, sex and day of illness of measurement. 
Significance of partial correlations was assessed based on their Fisher transformation and corresponding bootstrap standard errors. 
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